Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study

This 2-stage Phase III study (NCT04142242) of a recently licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) assessed the safety and immunogenicity of a booster dose in older adults (≥59 years) primed with either MenACYW-TT or a quadrivalent meningococcal polysaccharide...

Descripción completa

Detalles Bibliográficos
Autores principales: Robertson, Corwin A., Jacqmein, Jeffry, Selmani, Alexandre, Galarza, Katherine, Oster, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Meningococcal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980625/
https://www.ncbi.nlm.nih.gov/pubmed/36632042
http://dx.doi.org/10.1080/21645515.2022.2160600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980625/
https://www.ncbi.nlm.nih.gov/pubmed/36632042
http://dx.doi.org/10.1080/21645515.2022.2160600

Ejemplares similares